Phse

Founded in PHSE is today a market leader providing GDP compliant time-critical and temperature-sensitive transport solutions to the pharmaceutical, biotech and life sciences industry, serving the hospital, home care and clinical research channels. It ranks internationally among the few providers specialising exclusively in the healthcare segment and in the management of worldwide shipments by air, land and sea of pharmaceuticals, radiopharmaceuticals, biotech, clinical trials, biological samples and celle & gene therapies, at any required temperature conditions. The year 2020 marks an important step in the development of PHSE's international platform, which counts 5 acquisitions between 2021 and 2023: TEK Freight (UK), Rapida Time and Temperature (India), Duimex (Italy) and Bio Transportes (Brazil), Air Plus (2023).